Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

Conditions

• Biliary Tract Cancer (BTC)
• First-line Therapy

Interventions

• DRUG: Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Overexpression BTC
• DRUG: Trastuzumab-rezetecan + Pertuzumab + Iparomlimab and Tuvonralimab for HER2 Moderate/Low BTC

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology